S&P global ratings is out with its assessment of the impact of the coronavirus outbreak on the Chinese economy.
Coronavirus will deliver a short-term blow to economic growth in the first quarter in China.
Assuming coronavirus is contained in march, expect China’s GDP growth rate to recover firmly in Q3, before rebounding in 2021.
Expect small and medium-sized restaurant firms to come under stress in china from coronavirus, as store closures pile on liquidity pressure.
Believe the long-term outlook for hardware and software remains positive in China.
Structured finance sector is expected to see a short-term impact from coronavirus.
Coronavirus has highlighted vulnerabilities that exist across China's tourism sector.
Earlier today, S&P said that it sees “material knock to growth” for Australia from coronavirus and therefore the RBA will be forced to cut rate further.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.